Covid-19 vaccine

Investors should consider the risk of a successful coronavirus vaccine unsettling markets by sparking a sell-off in bonds and rotation out of technology into cyclical stocks, according to Goldman Sachs Group Inc.

Singapore sought out US Covid-19 vaccine developer Arcturus Therapeutics Holdings Inc. and is funding its research in order to secure the first doses of any successful final product, in a reflection of the growing urgency in the race for immunisation.

During a results briefing by Manulife US REIT’s manager on Aug 3, Jill Smith, CEO of the manager was upbeat about prospects for a vaccine against Covid-19, and hence expects an economic rebound in 2H2020. MUST owns nine properties in the US, of which tw